X

MEDS

Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent…

TRxADE Health Inc (MEDS) Q3 2022 Earnings Call Transcript

TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Founder,…

Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile,…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent…

TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman — Chief Financial Officer Suren…

TRxADE HEALTH, Inc. (MEDS) Q2 2022

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 Earnings Conference

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more…

TRxADE HEALTH Inc. (MEDS) Q1 2022 Earnings Call Transcript

TRxADE HEALTH Inc.  (NASDAQ: MEDS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Janet Huffman — Chief Financial Officer Suren…

Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens

Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It…